BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee ...
Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback